Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

NV-06: Began Phase I/II trial

September 5, 2000 7:00 AM UTC

Separately, NVGN said it completed a pharmacokinetic study of continuous infusion of NV-06 in 5 patients with breast or prostate cancer. The patients were part of a previously completed 6-patient Phas...